Coyne Terrance P. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Coyne Terrance P.（CIK 1814876）在 1 家公司共报告 41 笔 SEC Form 4 内部人交易（最近一笔 2026-08-17）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-17 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 9,230 | $540,752 |
| 2026-08-17 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 1,772 | $104,799 |
| 2026-08-07 | Royalty Pharma plc (RPRX) | EVP & CFO | 买入 | 11,002 | $0 |
| 2026-05-28 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 64,399 | $3.5M |
| 2026-05-08 | Royalty Pharma plc (RPRX) | EVP & CFO | 买入 | 24,263 | $0 |
| 2026-04-30 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 32,916 | $1.6M |
| 2026-04-30 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 1,875 | $93,338 |
| 2026-04-02 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 1,875 | $90,619 |
| 2026-04-02 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 32,916 | $1.6M |
| 2026-03-25 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 32,916 | $1.5M |
| 2026-03-25 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 1,875 | $85,369 |
| 2026-03-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 10,429 | $490,267 |
| 2026-03-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 22,487 | $1.0M |
| 2026-03-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 1,292 | $60,298 |
| 2026-03-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 583 | $27,407 |
| 2026-02-25 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 32,916 | $1.5M |
| 2026-02-25 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 1,875 | $84,975 |
| 2026-02-13 | Royalty Pharma plc (RPRX) | EVP & CFO | 买入 | 26,626 | $0 |
| 2026-02-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 102,581 | $4.3M |
| 2026-02-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 108,759 | $4.7M |
| 2026-02-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 19,076 | $825,800 |
| 2026-02-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 5,843 | $245,873 |
| 2026-02-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 6,195 | $265,394 |
| 2026-02-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 1,087 | $47,056 |
| 2026-01-23 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 65,832 | $2.6M |
来源：SEC Form 4 申报文件 · 截至 2026-08-17